Book an Accurate Mantoux Test in Karachi at Dr. Essa Lab

Mantoux Test at Dr. Essa Lab

The Mantoux Test, also known as the Tuberculin Skin Test (TST), is a fundamental diagnostic tool used worldwide to screen for infection by Mycobacterium tuberculosis, the causative bacterium of tuberculosis (TB). As a high-burden TB country, Pakistan requires highly accurate, accessible, and professionally administered screening methods. Dr. Essa Laboratory & Diagnostic Centre, a pioneer in diagnostic services in Karachi, Pakistan, offers standardized Mantoux testing performed by highly trained clinical staff under strict quality control protocols.

The test works on the principle of a delayed-type hypersensitivity (Type IV) reaction. When a small amount of Purified Protein Derivative (PPD)—a sterile extract derived from cultures of Mycobacterium tuberculosis—is injected intradermally into the skin, it triggers a localized immune response in individuals who have previously been exposed to the bacterium. This response is mediated by sensitized T-lymphocytes, which migrate to the injection site and release cytokines, causing localized cellular infiltration, edema, and induration (hardening of the skin) over a period of 48 to 72 hours.

The primary clinical importance of the Mantoux Test lies in its ability to detect latent tuberculosis infection (LTBI) as well as aid in the diagnosis of active tuberculosis, especially in pediatric patients, immunocompromised individuals, and close contacts of confirmed TB cases. Early detection of LTBI is a cornerstone of global public health strategies, as it allows for preventive therapy before the infection progresses to active, transmissible disease. At Dr. Essa Lab, we utilize premium-quality, standardized PPD antigens and adhere strictly to international guidelines for administration and measurement, ensuring the highest diagnostic accuracy for our patients.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the validity of the Mantoux Test and to prevent false-negative or false-positive results. Patients visiting Dr. Essa Lab should observe the following guidelines:

• No Fasting Required: There is no need to fast before the test. You may eat, drink, and take your regular medications as usual.
• Disclose Medical History: Inform the healthcare provider if you have ever had a severe reaction to a previous Mantoux test, as repeating the test in highly sensitive individuals can cause localized ulceration or necrosis.
• Vaccination History: Disclose any recent vaccinations. Live virus vaccines (such as MMR, varicella, or yellow fever) can temporarily suppress your body’s immune response, leading to a false-negative Mantoux result. It is recommended to either get the Mantoux test on the same day as live vaccines or wait at least 4 to 6 weeks afterward.
• Medication Disclosure: Inform the clinical staff if you are taking immunosuppressive medications, systemic corticosteroids, or chemotherapy, as these drugs can suppress the delayed-type hypersensitivity reaction.
• Skin Care: Ensure the skin on the inner aspect of your forearm is free from active rashes, lesions, extensive scars, or tattoos, as these can interfere with the administration and reading of the test.

During the Procedure

The Mantoux Test is a two-step clinical procedure requiring two separate visits to Dr. Essa Lab: the first for the injection and the second, exactly 48 to 72 hours later, for the reading of the result.

Step 1: The Injection (Day 1)

• The patient is seated comfortably, and the inner (volar) surface of the forearm is selected. The skin is cleansed with an alcohol swab and allowed to air dry completely.
• Using a sterile, single-use tuberculin syringe fitted with a short, fine 26- or 27-gauge needle, the phlebotomist carefully injects exactly 0.1 mL of Purified Protein Derivative (containing 5 Tuberculin Units) intradermally.
• The needle is inserted bevel up at an angle of 5 to 15 degrees. When performed correctly, the injection produces a pale, well-demarcated elevation of the skin (a wheal) measuring approximately 6 to 10 mm in diameter. If no wheal forms, the injection was too deep (subcutaneous), and the test must be repeated immediately on the other arm or at a site at least 2 inches away.
• The site is left uncovered; no bandages or ointments should be applied. The patient is instructed not to scratch, rub, or massage the area.

Step 2: The Reading (Day 3 / 48 to 72 Hours Later)

• The patient must return to Dr. Essa Lab within 48 to 72 hours. A trained healthcare professional will inspect and palpate the injection site.
• The evaluator will locate the margins of the induration (the hard, raised area) by running a fingertip or a pen across the skin. Only the induration is measured; localized redness (erythema) is ignored, as it does not indicate a specific immune response.
• The transverse diameter of the induration (perpendicular to the long axis of the forearm) is measured in millimeters using a standardized transparent ruler. The result is documented precisely.

When is a Mantoux Test Performed?

Active Tuberculosis Symptoms

Physicians frequently request a Mantoux Test when a patient presents with clinical symptoms suggestive of active pulmonary or extrapulmonary tuberculosis. These symptoms include a persistent cough lasting more than three weeks, hemoptysis (coughing up blood), unexplained weight loss, chronic low-grade fever, drenching night sweats, fatigue, and loss of appetite. In these cases, the test serves as a supportive diagnostic tool alongside chest radiography and sputum microbiology.

Latent TB Screening for High-Risk Groups

Screening for latent tuberculosis infection (LTBI) is highly recommended for individuals who are at an increased risk of acquiring TB or progressing from latent to active disease. This includes healthcare workers, laboratory personnel, individuals residing or working in high-risk congregate settings (such as correctional facilities or nursing homes), and travelers returning from regions with high TB prevalence. Identifying and treating LTBI in these groups prevents future outbreaks.

Pre-Employment and Institutional Screening

Many academic institutions, medical colleges, hospitals, and corporate organizations in Pakistan require a baseline Mantoux Test as part of their pre-employment or pre-admission health screening. This protocol protects the institutional environment, particularly in healthcare settings where staff are routinely exposed to patients with infectious diseases, ensuring a safe working and learning space.

Prior to Immunosuppressive Therapy

Before initiating medical therapies that suppress the immune system, physicians must rule out latent TB. These therapies include tumor necrosis factor (TNF) alpha inhibitors, long-term systemic corticosteroids, chemotherapy, or immunosuppressants used before and after organ transplantation. If a patient with latent TB starts these medications without preventive therapy, the risk of the infection reactivating into severe, disseminated active TB is extremely high.

Close Contact with Active TB Patients

When a patient is diagnosed with active, infectious pulmonary tuberculosis, contact tracing is initiated. Family members, close friends, and co-workers who have spent significant time with the infectious individual are advised to undergo a Mantoux Test. This helps identify newly infected individuals who require immediate prophylactic treatment to halt the transmission cycle.

What Does a Mantoux Test Detect?

The Mantoux Test is designed to detect the presence of a cell-mediated immune response to Mycobacterium tuberculosis. It does not measure the severity of the disease, nor does it definitively distinguish between active tuberculosis and latent tuberculosis infection. Instead, the test detects:

• Prior Exposure to TB: A positive reaction indicates that the patient’s immune system has previously encountered tuberculosis proteins and has developed sensitized T-lymphocytes.
• Latent Tuberculosis Infection (LTBI): The presence of viable, dormant TB bacilli in the body without clinical symptoms or radiological evidence of active disease.
• Active Tuberculosis Infection: In conjunction with clinical symptoms, positive sputum smears, and chest X-rays, a positive Mantoux test supports the diagnosis of active TB.
• Hypersensitivity to Tuberculin: The degree of cellular immune response, which varies based on the patient’s immune status and risk factors.
• Anergy or Lack of Immune Response: A completely flat injection site (0 mm induration) in a patient with suspected TB may indicate anergy, which occurs when a severely compromised immune system (due to advanced HIV, malnutrition, or overwhelming systemic infection) cannot mount a reaction.
• Cross-Reactivity with BCG Vaccine: The test can detect immune sensitization caused by prior vaccination with the Bacillus Calmette-Guérin (BCG) vaccine, which is widely administered at birth in Pakistan.
• Exposure to Non-Tuberculous Mycobacteria (NTM): Occasional mild cross-reactivity can occur due to exposure to environmental, non-tuberculous mycobacterial species.

Turnaround Time and Report Access at Dr. Essa Lab

Because the Mantoux Test relies on a physiological delayed-type hypersensitivity reaction that takes time to manifest, the turnaround time is strictly dependent on the clinical window of 48 to 72 hours. Patients must return to the same Dr. Essa Lab branch where the injection was administered to have the skin reaction evaluated by a professional.

Once the clinical reading is performed and the induration is measured in millimeters, the official report is generated immediately. Dr. Essa Lab offers seamless digital access to diagnostic reports. Patients can view, download, and print their verified reports online through the official Dr. Essa Lab web portal or mobile application, eliminating the need for a second trip to collect physical papers. This digital integration ensures that patients can promptly share their results with their referring physicians.

Mantoux Test Findings Overview

The interpretation of the Mantoux Test is not uniform; the threshold for a “positive” result depends entirely on the patient’s clinical history, immune status, and risk factors. The table below outlines the standard clinical interpretation guidelines:

Induration Size (mm)	Patient Risk Category / Clinical Context	Interpretation
< 5 mm	All individuals, regardless of risk factors.	Negative reaction. No significant immune response detected.
≥ 5 mm	HIV-positive individuals; recent close contacts of active TB patients; patients with fibrotic changes on chest X-ray consistent with old healed TB; organ transplant recipients; other immunosuppressed patients.	Positive reaction. Indicates high risk of infection in these vulnerable groups.
≥ 10 mm	Recent immigrants from high-prevalence countries; injection drug users; residents and employees of high-risk congregate settings; mycobacteriology laboratory personnel; individuals with clinical conditions that increase TB reactivation risk (e.g., diabetes, chronic renal failure, silicosis); children under 4 years of age.	Positive reaction. Indicates a significant likelihood of tuberculosis infection.
≥ 15 mm	Individuals with no known risk factors for tuberculosis.	Positive reaction. Indicates tuberculosis infection despite low baseline risk.
0 mm (No reaction)	Suspected active TB patients with severe illness, advanced HIV, or malnutrition.	Possible Anergy. The immune system is too weak to react; does not rule out TB.
Vesiculation / Ulceration	Any patient showing blistering, necrosis, or severe local pain at the site.	Strongly Positive. Indicates extreme hypersensitivity to tuberculin.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Mantoux Test?

• Experienced Healthcare Professionals: Our clinical staff are highly trained in the precise intradermal administration of PPD, ensuring accurate wheal formation and reliable results.
• Standardized Testing Protocols: We use only premium, internationally approved, and properly stored tuberculin antigens to prevent false-negative outcomes.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the two-step testing process.
• Quality Diagnostic Services: Dr. Essa Lab is a trusted name in Pakistan, recognized for maintaining stringent quality control and laboratory standards.
• Convenient Digital Reports: Access your verified Mantoux Test reports online through our secure web portal or mobile application as soon as the reading is completed.
• Extensive Branch Network: With multiple conveniently located branches across Karachi and other major cities, finding a location near you is simple.
• Clean and Safe Environment: We maintain the highest standards of hygiene and infection control across all our collection centers.
• Comprehensive Diagnostic Support: If your Mantoux test is positive, Dr. Essa Lab offers a full suite of follow-up diagnostics, including digital chest X-rays, sputum AFB smears, GeneXpert PCR testing, and IGRA blood tests.